The Financial Comet
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

The Financial Comet

Investing

Acceleration of RAD204 Phase 1 dose escalation trial

by admin May 12, 2025
May 12, 2025
Acceleration of RAD204 Phase 1 dose escalation trial

Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial

Download the PDF here.

This post appeared first on investingnews.com

previous post
Multiple New Multi-Commodity Targets
next post
Excellent Gold Intersections Verified at Kiimala Project

Related Posts

Tech 5: US Lifts EDA Restrictions for China,...

July 6, 2025

Avalanche Treasury Co.: Bridging Crypto Innovation and Institutional...

October 31, 2025

You’re invited to join Osisko Metals at PDAC...

March 1, 2025

Heritage Mining Announces Closing of Strategic Investment

May 15, 2025

Regulator: New York Taking Strong Steps in Bid...

May 21, 2025

Proposed issue of securities – JLL

October 20, 2025

Top 10 Aluminum-producing Countries

February 19, 2025

Challenger Gold Doubles Ecuador Resource to 9.1¹ Million...

April 9, 2025

Nebius Shares Soar on US$17.4 Billion Microsoft AI...

September 10, 2025

Stallion Uranium Announces Update to Previously Announced Technology...

August 1, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      DeepSeek hit with large-scale cyberattack, says it’s limiting registrations

      January 28, 2025
    • 2

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 3

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 27, 2025
    • 4

      UnitedHealthcare taps company veteran Tim Noel as new CEO following Brian Thompson killing

      January 27, 2025
    • 5

      Bank of America CEO says financial industry will jump into crypto payments if regulators allow it

      January 23, 2025
    • 6

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • 7

      Lara Trump to host weekend show on Fox News

      February 7, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: thefinancialcomet.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 thefinancialcomet.com | All Rights Reserved